Winter boots are difficult to pack, but their bulky size can be used to your advantage. Here's how to pack your boots for ...

Lilly Pulitzer is serving up a Valentine’s Day partnership with Lele Sadoughi, the New York-based accessories brand. Marking ...

The daughter of Steven Gerrard is expecting her first baby with the son of one of Ireland’s most notorious gangsters. Influencer Lilly-Ella Gerard shared a picture of scans with her 216,000 ...

Lululemon is kicking off the new year right and is offering a variety of its best-sellers, including yoga pants, belt bags, ...

The highly anticipated East Coast salad chain Sweetgreen is coming to Scottsdale Quarter in 2025. But that's not the only new addition at the popular outdoor shopping mall on the Scottsdale ...

Ann Telnaes, an editorial cartoonist who has worked for The Washington Post since 2008, announced she was quitting her position after one of her cartoons was rejected. The cartoon in question ...

After a compounding group sued the FDA over its decision to declare the shortage of tirzepatide over, Eli Lilly is looking to muscle in on the case.

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market. Lilly’s ...

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

Senior equity analysts at StockNews.com upgraded Eli Lilly (LLY, Financial) stock from 'hold' to 'buy' as its stock has shifted positively. Analysts say the upgrade is a sign of increased ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.